# Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

> **NCT01244503** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 61 (actual)

## Conditions studied

- Metabolic Syndrome
- Nonalcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Sodium Octanoate Breath Test

## Key facts

- **NCT ID:** NCT01244503
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** Budgetary Issues
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244503, "Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01244503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*